Long-term cardiomyopathy risk varies by chemo agent

(HealthDay)—Long-term cardiomyopathy risk varies by chemotherapy agent for childhood cancer survivors, with a decreased risk for daunorubicin versus doxorubicin, according to a study recently publishe

Updated on: April 18,2024

Long-term cardiomyopathy risk varies by chemo agent

(HealthDay)—Long-term cardiomyopathy risk varies by chemotherapy agent for childhood cancer survivors, with a decreased risk for daunorubicin versus doxorubicin, according to a study recently publishe

Updated on:April 18,2024

Health insurance premiums dropped? Not so fast

by E.J. Antoni, The Heritage FoundationCredit: Pixabay/CC0 Public DomainThe latest Consumer Price Index report showed inflation slowing in October, due in part to a supposed 34% drop in the cost of he

Updated on: May 17,2024

Health insurance premiums dropped? Not so fast

by E.J. Antoni, The Heritage FoundationCredit: Pixabay/CC0 Public DomainThe latest Consumer Price Index report showed inflation slowing in October, due in part to a supposed 34% drop in the cost of he

Updated on:May 17,2024

Researches novel triple-negative breast cancer treatments

by Medical University of South CarolinaDr. Antonio Giordano received an award that will help him research triple-negative breast cancer treatments. Credit: Sarah PackWorking with patients while a

Updated on: May 27,2024

Researches novel triple-negative breast cancer treatments

by Medical University of South CarolinaDr. Antonio Giordano received an award that will help him research triple-negative breast cancer treatments. Credit: Sarah PackWorking with patients while a

Updated on:May 27,2024

Researchers uncover potential biomarkers of positive response to immunotherapy

by Denise Heady,University of California, Los AngelesResponse to ICI or MAPKi therapy is associated with increased T cell infiltration and enhanced interferon gamma (IFNγ) pathway activity in th

Updated on: January 30,2024

Researchers uncover potential biomarkers of positive response to immunotherapy

by Denise Heady,University of California, Los AngelesResponse to ICI or MAPKi therapy is associated with increased T cell infiltration and enhanced interferon gamma (IFNγ) pathway activity in th

Updated on:January 30,2024

Too often, women aren't told of sexual side effects of cancer treatments

by Cara MurezWhen a man has cancer in an area that affects sexual function, his doctor is likely to discuss it with him.But the same is not true for a woman who has cancer in a sex organ, according to

Updated on: January 02,2024

Too often, women aren't told of sexual side effects of cancer treatments

by Cara MurezWhen a man has cancer in an area that affects sexual function, his doctor is likely to discuss it with him.But the same is not true for a woman who has cancer in a sex organ, according to

Updated on:January 02,2024

New regulator in aggressive breast cancer cells discovered

by Leibniz Institute on AgingThe protein TRPS1 controls the activity of the YAP protein in breast cancer. If YAP activity is downregulated, the survival prognosis for patients is reduced. If TRPS1 is

Updated on: April 22,2024

New regulator in aggressive breast cancer cells discovered

by Leibniz Institute on AgingThe protein TRPS1 controls the activity of the YAP protein in breast cancer. If YAP activity is downregulated, the survival prognosis for patients is reduced. If TRPS1 is

Updated on:April 22,2024

Physicians debate CRC guidelines, available screening options for younger patients

by American College of PhysiciansCredit: Pixabay/CC0 Public DomainIn a newAnnals of Internal Medicine"Beyond the Guidelines" feature, a primary care physician and a gastroen

Updated on: January 30,2024

Physicians debate CRC guidelines, available screening options for younger patients

by American College of PhysiciansCredit: Pixabay/CC0 Public DomainIn a newAnnals of Internal Medicine"Beyond the Guidelines" feature, a primary care physician and a gastroen

Updated on:January 30,2024

Neuronal molecule makes prostate cancer more aggressive

byThomas Jefferson UniversityCredit: Unsplash/CC0 Public DomainProstate cancer is the second most common cancer and the second leading cause of cancer death among American men. Now, researchers

Updated on: January 04,2024

Neuronal molecule makes prostate cancer more aggressive

byThomas Jefferson UniversityCredit: Unsplash/CC0 Public DomainProstate cancer is the second most common cancer and the second leading cause of cancer death among American men. Now, researchers

Updated on:January 04,2024

Researchers find link between obesity and blood cancer

by Jackie Maupin,Indiana University School of MedicineCredit: Unsplash/CC0 Public DomainIndiana University School of Medicine researchers studying clonal hematopoiesis of indeterminate potential

Updated on: February 01,2024

Researchers find link between obesity and blood cancer

by Jackie Maupin,Indiana University School of MedicineCredit: Unsplash/CC0 Public DomainIndiana University School of Medicine researchers studying clonal hematopoiesis of indeterminate potential

Updated on:February 01,2024

Genomic sequencing panels to personalize cancer treatment beneficial in only 5% of the patients, finds study

byThe Spanish National Cancer Research CentreThe use of these panels following the recommended clinical criteria increases the efficacy of treatments and patient survival. Credit: underbau / CNI

Updated on: January 23,2024

Genomic sequencing panels to personalize cancer treatment beneficial in only 5% of the patients, finds study

byThe Spanish National Cancer Research CentreThe use of these panels following the recommended clinical criteria increases the efficacy of treatments and patient survival. Credit: underbau / CNI

Updated on:January 23,2024

Study suggests tumor mutational load may be useful metric to predict response to checkpoint-inhibitor immunotherapy

by Bob Yirka , Medical XpressCredit: CC0 Public DomainA large team of researchers affiliated with Sloan Kettering Cancer Center, Weill Cornell Medical Center and Columbia University Medical Center has

Updated on: March 08,2024

Study suggests tumor mutational load may be useful metric to predict response to checkpoint-inhibitor immunotherapy

by Bob Yirka , Medical XpressCredit: CC0 Public DomainA large team of researchers affiliated with Sloan Kettering Cancer Center, Weill Cornell Medical Center and Columbia University Medical Center has

Updated on:March 08,2024

Insurance status mediates racial, ethnic inequities in cervical cancer, finds study

by Elana GotkineInsurance status mediates racial and ethnic inequities in advanced-stage cervical cancer diagnosis, according to a study published online March 10 inJAMA Network Open.Hunter K. H

Updated on: January 23,2024

Insurance status mediates racial, ethnic inequities in cervical cancer, finds study

by Elana GotkineInsurance status mediates racial and ethnic inequities in advanced-stage cervical cancer diagnosis, according to a study published online March 10 inJAMA Network Open.Hunter K. H

Updated on:January 23,2024